 | Up a level |
Merola, E; Pascher, A; Rinke, A; Bartsch, D K; Zerbi, A; Nappo, G; Carnaghi, C; Ciola, M; McNamara, M G; Zandee, W; Bertani, E; Marcucci, S; Modica, R; Grützmann, R; Fazio, N; de Herder, W; Valle, J W; Gress, T M; Fave, G Delle; de Pretis, G; ... (2022). Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence. Annals of surgical oncology, 29(9), pp. 5568-5577. Springer 10.1245/s10434-022-11837-1
Merola, E; Pascher, A; Rinke, A; Bartsch, D K; Zerbi, A; Nappo, G; Carnaghi, C; Ciola, M; McNamara, M G; Zandee, W; Bertani, E; Marcucci, S; Modica, R; Grützmann, R; Fazio, N; de Herder, W; Valle, J W; Gress, T M; Delle Fave, G; de Pretis, G; ... (2022). ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence. Annals of surgical oncology, 29(9), pp. 5580-5581. Springer 10.1245/s10434-022-12049-3
Knigge, U; Capdevila, J; Bartsch, D K; Baudin, E; Falkerby, J; Kianmanesh, R; Kos-Kudla, B; Niederle, B; Nieveen van Dijkum, E; O'Toole, D; Pascher, A; Reed, N; Sundin, A; Vullierme, M-P; Perren, Aurel (2017). ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation. Neuroendocrinology, 105(3), pp. 310-319. Karger 10.1159/000458155
Abdelmalek, M F; Humar, A; Stickel, F; Andreone, P; Pascher, A; Barroso, E; Neff, G W; Ranjan, D; Toselli, L T; Gane, E J; Scarola, J; Alberts, R G; Maller, E S; Lo, C-M; Sirolimus Liver Conversion Trial Study Group, (2012). Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial. American journal of transplantation, 12(3), pp. 694-705. Oxford: Wiley-Blackwell 10.1111/j.1600-6143.2011.03919.x
